The pharmaceutical and healthcare sector is one of the world’s most vital and innovative.
Against a backdrop of technological change and an increasing and aging population, we partner with our clients to help them achieve their goals, capitalise on opportunities and navigate uncertainty.
Combining deep scientific, technical and strategic knowledge we help our clients by providing the commercial nous, experience and range of services that only a large international professional services firm can offer, to anticipate and deliver innovative and value-enhancing solutions.
Advising AbbVie on its proposed US$55 billion takeover of Shire, a FTSE-100 pharmaceutical company
Claris Life Sciences Limited
Acting for Claris Life Sciences Limited on the sale of its Global Generic Injectables Business to Baxter for US$ 625 million
Representing Gilead in the successful defence of claims for patent infringement in both the UK and Australia brought by Idenix. These claims related to Gilead’s cure for Hepatitis C, sofosbuvir, worth over $10 billion in worldwide annual sales
Representing Ariosa, a subsidiary of Roche, in patent infringement proceedings brought against it in both the English High Court and the Australian Federal Court in relation to its Harmony® non-invasive prenatal test
Advising Diageo in relation to product liability issues arising from the distribution of Thalidomide in the late 1950s/early 1960s.
BioPharma Credit PLC
Advising BioPharma Credit PLC, a new listed investment fund managed by Pharmakon Advisors LP and investing in the life sciences industry, on its proposed IPO and listing on the London Stock Exchange
Insights and updates
Diverse knowledge and in-depth expertise
Natalie is a Corporate and Mergers & Acquisitions partner with particular expertise in healthcare, aged care and advisory and transactional work for government clients. Natalie is Herbert Smith Freehills’ Sector Lead Partner for Healthcare.